Keeping You Connected

The LACMA keeps you up to date on the latest news,
policy developments, and events


LAHAN - CDPH Health Update: Use of Outpatient COVID-19 Therapeutics in California

LACDPH 4.1.22.png

The California Department of Public Health (CDPH) issued an update on the status of COVID-19 therapeutics in California, including the following key points:

  • There is no longer a limited supply of COVID-19 therapeutics in most locations. At this time, all outpatients with mild to moderate COVID-19 who are at risk for disease progression should be offered treatment, if eligible, based on the product EUA.
  • Sotrovimab is no longer authorized by the FDA for use in California due to increases of the Omicron sub-variant BA.2.
  • A new HHS Test to Treat Locator went live on 3/30/2022. This locator identifies facilities that can both test for SARS-CoV-2 and dispense COVID-19 therapeutics.

In LA County, facilities that are interested in becoming a Test to Treat provider or that would like to receive Paxlovid, molnupiravir or Evusheld can contact LAC DPH at Visit the LAC DPH Monoclonal & Antiviral Therapy for Non-Hospitalized Patients website for additional information regarding therapeutics in LA County.

Read the full CDPH update "Use of Outpatient COVID-19 Therapeutics in California"